Navigation Links
ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
Date:10/21/2008

nesday, October 29, 2008 at 9:00 am. The live webcast of the conference call will be accessible via ViroPharma's corporate website at http://www.viropharma.com. An audio archive will be available at the same address until November 15, 2008. To participate in the conference call, please dial 877-366-0713 (domestic) and 302-607-2000 (international). After placing the call, please tell the operator you wish to join the ViroPharma investor conference call.

About Cinryze C1 Inhibitor (human)

Cinryze is a highly purified, pasteurized and nanofiltered plasma-derived C1 inhibitor product that has been approved by FDA for routine prophylaxis against angioedema attacks in adolescent and adult patients with HAE. C1 inhibitor therapy has been used acutely for more than 30 years in Europe to treat patients with C1 inhibitor deficiency.

In the Phase 3 prophylactic treatment trial, Cinryze significantly decreased the number of HAE attacks compared to placebo. The trial had a crossover design with 22 subjects in the efficacy data set. The difference between the number of angioedema attacks during treatment with Cinryze and the number during treatment with placebo was statistically significant (p<0.0001). During 12 weeks of prophylactic treatment with Cinryze, the number of attacks per patient ranged from 0 to 17 with a mean of 6.1 and a median of 6 attacks. During 12 weeks of treatment with placebo, the number of attacks per patient ranged from 6 to 22 with a mean of 12.7 and a median of 13.5 attacks. The clinically and statistically significant results for the primary endpoint demonstrating the efficacy of Cinryze were supported by statistically significant and clinically meaningful differences in all of the secondary endpoints, with Cinryze demonstrating reductions in the severity and duration of attacks and the number of days of swelling.

Cinryze has been well tolerated. The most common adverse rea
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
2. ViroPharma Announces Discontinuation of HCV-796 Development
3. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
4. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
5. ViroPharma to Present at the Natixis Bleichroeder Conference
6. ViroPharma to Present at Three Upcoming Healthcare Conferences
7. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
8. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
9. Genta Incorporated Announces Third Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Environmental health advocates hope that U.S. FDA will ... bisphenol A (BPA), a synthetic sex hormone linked ... illnesses, in time for Christmas. ,, Sarah ... Natural Resources Defense Council : "Just as ... FDA must rely on the advice of scientific ...
(Date:12/14/2009)... CLAREMONT, Calif., Dec. 14 The ... College today released the analysis of social ... companies world-wide. The report contains a compilation ... the environmental and social reporting of the ... intent, and performance for both environmental and ...
(Date:12/14/2009)... -- According to Millennium Research Group (MRG), the ... use of safety devices for small-bore connectors for ... driver of the enteral feeding device markets in ... US and European Markets for Enteral Feeding Devices ... segment will experience the greatest impact from facilities ...
Breaking Medicine Technology:Toxic Chemical bisphenol A Still Not Banned By FDA; Schumer, Gillibrand Call for Ban; Govt Official Warns Public 2New Report Grades Sustainability Reporting of Top Pharmaceutical Companies 2New Report Grades Sustainability Reporting of Top Pharmaceutical Companies 3Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3Shire Targets Fourth Quarter Filing of BLA for REPLAGAL 28R 29 for Fabry Disease With U S FDA 5629 1Shire Targets Fourth Quarter Filing of BLA for REPLAGAL 28R 29 for Fabry Disease With U S FDA 5629 2Shire Targets Fourth Quarter Filing of BLA for REPLAGAL 28R 29 for Fabry Disease With U S FDA 5629 3Shire Targets Fourth Quarter Filing of BLA for REPLAGAL 28R 29 for Fabry Disease With U S FDA 5629 4Vestara Joins National Health Organization Practice Greenhealth to Further Support Environmental Practices 59887 1Vestara Joins National Health Organization Practice Greenhealth to Further Support Environmental Practices 59887 2Vestara Joins National Health Organization Practice Greenhealth to Further Support Environmental Practices 59887 3Gluten Free Superstore Opens With 4 000 Products 59885 1Gluten Free Superstore Opens With 4 000 Products 59885 2
... of Nutrition ... Annual Meeting, ... children and seniors was presented at The American College of,Nutrition (ACN) ... Disease." Scientific experts in the fields of,pediatrics, aging, and nutrition discussed ...
... More than 60 percent of moderate to severe ... achieved endoscopic remission at Week 10,in data from ... College,of Gastroenterology (ACG) Annual Scientific Meeting, ORLANDO, ... from a,large, prospective study investigating endoscopic improvement in ...
Other Medicine Technology:'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7
(Date:12/14/2009)... Exercise benefited men whose disease had been treated, hadn,t ... -- Exercise appears to reduce the risk of death ... study, which began in January 1986, included 668 men ... stage III colon cancer that had not spread (nonmetastatic ... that asked them about any new cancer and disease ...
(Date:12/14/2009)... some protection, study finds, , , MONDAY, Dec. 14 (HealthDay ... start their morning without a cup or two of ... of developing type 2 diabetes. , That,s the ... more coffee you drink, the lower your risk of ... 7 percent reduction in the risk of diabetes, the ...
(Date:12/14/2009)... treated and highly stigmatized, according to psychiatrists Charles ... Ph.D. So these Washington University physicians have written ... "Demystifying Psychiatry," Zorumski and Rubin, who have more ... and helping patient families, say some of the ... from a lack of understanding psychiatry and what ...
(Date:12/14/2009)... rates for meth and smoking, but concerns about ... News) -- Fewer teenagers are using methamphetamine, but ... of prescription drugs remains high, U.S. health officials ... drugs, such as the hallucinogenic salvia leaf and ... treatment of attention-deficit hyperactivity disorder (ADHD), appear to ...
(Date:12/14/2009)... Home now provides in-home caregivers who have been certified by ... rehab therapy, caregiver, and hospice services to San Francisco Bay ... ... CA (PRWEB) December 14, 2009 -- Professional HealthCare at Home, ... health care, including nursing, rehab, personal caregiver and hospice services, ...
Breaking Medicine News(10 mins):Health News:Physical Activity May Prolong Survival After Colon Cancer 2Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3Health News:Book demystifies psychiatry for the general public 2Health News:Book demystifies psychiatry for the general public 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 4Health News:Caregivers with Professional HealthCare at Home Now Certified by the Alzheimer's Association 2
... Church officials have communicated Pope Benedict XVI’s intention of soliciting ... the benefits of condom use //in exceptional cases, such as, ... with a view to protect life within the precincts of ... to have addressed a sensitive issue such as this, while ...
... with seasons? An exhaustive study on suicide has revealed that ... or summer//. ,Researchers analyzed some 26,915 suicides ... and revealed that those born in the summer and spring ... inclination to attempt suicide. This tendency was more pronounced amongst ...
... Organization WHO has recently released its first-ever international growth ... United Nations health agency found that all children are ... nurtured and they claimed that the new guidelines were ... says it now has scientific evidence that infants and ...
... National Party raised its fears that the new immigration ... UK,// after they were informed that 13% of the ... ,The opposition MSPs warned the new regulations could have ... mostly from the Indian subcontinent but also from Africa, ...
... College of Nursing congress last week shouted at Patricia Hewitt ... their hostility to a government which was a great ally ... and what are they furious about? There are 70,000 nurses ... has also risen considerably over the past three years. Les ...
... published in the May issue of The American Journal of ... males as well. Low levels of the female// sex hormone ... found. Those who had low levels of both estrogen and ... conducted by Shreyasee Amin, M.D., Mayo Clinic rheumatologist, and colleagues ...
Other Medicine News:Health News:An International Growth Standard For Childs Releases By WHO 2Health News:Hip Fracture Risk Increases In Men Having Low Estrogen Levels 2
3.5v Standard Ophthalmoscope Set with Convertible Handle and Soft Case. Our Standard Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
High-quality eyecare from the preferred name in diagnostic instruments....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Testing for Strabismus (ocular misalignment) just became easier. By simply placing the StrabismoScope over the patient's eye, the examiner is able to observe the occluded eye directly, but the patien...
Medicine Products: